Chicago, Illinois, United States Orchard Venture Partners appeared to be the Corporate Investor, which was created in 2004. The main office of represented Corporate Investor is situated in the Chicago. The venture was found in North America in United States.
Among the various public portfolio startups of the fund, we may underline Logical Therapeutics, Nymirum, Kereos The fund has exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Medical.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Orchard Venture Partners, startups are often financed by Venture Investors, Triathlon Medical Venture Partners, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Triathlon Medical Venture Partners, Venture Investors, Novartis Venture Fund. In the next rounds fund is usually obtained by Venture Investors, Triathlon Medical Venture Partners, Novo Holdings.
The top activity for fund was in 2005. This Orchard Venture Partners works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Armory Capital | Champaign, Illinois, United States |
| BMNT | California, Palo Alto, United States |
| CCB Principal Asset Management | Beijing, Beijing, China |
| Esfin Gestion | Courbevoie, France, Ile-de-France |
| Goodworks Ventures | Missoula, Montana, United States |
| Groupe Aeroplan | Canada, Montreal, Quebec |
| Heidelpay | Baden-Wurttemberg, Germany, Heidelberg |
| Macnica Ventures | - |
| METRO GROUP | Düsseldorf, Germany, Nordrhein-Westfalen |
| Network Society Ventures | New York, New York, United States |
| OBI SA | - |
| QVC | Pennsylvania, United States, West Chester |
| Seastar | China, Dalian Shi, Liaoning |
| Semantic Ventures | England, London, United Kingdom |
| SK Hynix | Seoul, Seoul-t'ukpyolsi, South Korea |
| Startupbootcamp Smart Transportation & Energy Berlin | Berlin, Berlin, Germany |
| Terrapin Bale Venture Fund & Studio | Stockholm, Stockholm County, Sweden |
| THine Electronics | Japan, Tokyo |
| Venture One | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GuideCX, Inc. | $10M | 12 Nov 2020 | Utah, United States | ||
Akebia Therapeutics | $41M | 04 Jun 2013 | Cambridge, Massachusetts, United States | ||
Akebia Therapeutics | $22M | 26 Apr 2011 | Cambridge, Massachusetts, United States | ||
Akebia Therapeutics | $25M | 28 Jul 2009 | Cambridge, Massachusetts, United States | ||
Logical Therapeutics | $30M | 13 Jun 2007 | Massachusetts, United States | ||
Kereos | $19M | 20 Sep 2005 | City of Saint Louis, Missouri, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GuideCX, Inc. | $10M | 12 Nov 2020 | Utah, United States | ||
Akebia Therapeutics | $41M | 04 Jun 2013 | Cambridge, Massachusetts, United States | ||
Akebia Therapeutics | $22M | 26 Apr 2011 | Cambridge, Massachusetts, United States | ||
Akebia Therapeutics | $25M | 28 Jul 2009 | Cambridge, Massachusetts, United States | ||
Logical Therapeutics | $30M | 13 Jun 2007 | Massachusetts, United States | ||
Kereos | $19M | 20 Sep 2005 | City of Saint Louis, Missouri, United States |
